• SQI Diagnostics Updates Clinical Progress on Novel COVID-19 Tests americanpharmaceuticalreview
    October 30, 2020
    SQI Diagnostics updated the Company's clinical development progress for its three novel Covid-19 tests, highlighted by confirmation from the U.S. Food and Drug Administration (FDA) that Emergency Use Authorization (EUA) submission is acceptable for ...
PharmaSources Customer Service